2023年12月最新中科院分区表数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH J EXP CLIN CANC RES （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.7
60人评分
我要评分
声誉 8.2 影响力 7.0 速度 9.5 | |||||||||||||||||||||
| 期刊ISSN | 1756-9966 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| P-ISSN | 0392-9078 | |||||||||||||||||||||
| 2022-2023最新影响因子 （数据来源于搜索引擎） | 11.3 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2024年3月26日：11.21 | |||||||||||||||||||||
| 2022-2023自引率 | 1.80%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 11.5 | |||||||||||||||||||||
| h-index | 67 | |||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://jeccr.biomedcentral.com | |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/jecc/ | |||||||||||||||||||||
| 作者指南网址 | http://jeccr.biomedcentral.com/submission-guidelines | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH的语言要求，还能让JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ GBP2890; USD3990; EUR3390; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：oncology、cancer、human tumours 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | ITALY | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||
| 出版年份 | 2008 | |||||||||||||||||||||
| 年文章数 | 302点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.55% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 83.11% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2022-2023年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-9966%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均1月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约66.66% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization Author: Zhang, Nasha; Wang, Bowen; Ma, Chi; Zeng, Jiajia; Wang, Teng; Han, Linyu; Yang, Ming Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02654-9 PubMed DOI |
| 2. | FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling Author: Yang, Yiqi; Zhang, Yibo; Cao, Jieqiong; Su, Zijian; Li, Fu; Zhang, Peiguang; Zhang, Bihui; Liu, Rongzhan; Zhang, Linhao; Xie, Junye; Li, Jingsheng; Zhang, Jinting; Chen, Xiaojia; Hong, An Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02659-4 PubMed DOI |
| 3. | Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth Author: Jia, Xuechao; Wang, Penglei; Huang, Chuntian; Zhao, Dengyun; Wu, Qiong; Lu, Bingbing; Nie, Wenna; Huang, Limeng; Tian, Xueli; li, Pan; Laster, Kyle Vaughn; Jiang, Yanan; Li, Xiang; Li, Honglin; Dong, Zigang; Liu, Kangdong Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02666-5 PubMed DOI |
| 4. | Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development Author: Gao, Lixia; Yang, Fan; Tang, Dianyong; Xu, Zhigang; Tang, Yan; Yang, Donglin; Sun, Deping; Chen, Zhongzhu; Teng, Yong Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02574-0 PubMed DOI |
| 5. | KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2 Author: Zhou, Hui; Chen, Junru; Fan, Mingjie; Cai, Huajian; Dong, Yufei; Qiu, Yue; Zhuang, Qianqian; Lei, Zhaoying; Li, Mengyao; Ding, Xue; Yan, Peng; Lin, Aifu; Zheng, Shusen; Yan, Qingfeng Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02562-4 PubMed DOI |
| 6. | S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma Author: Wang, Xingtong; Guo, Wei; Shi, Xiaoju; Chen, Yujia; Yu, Youxi; Du, Beibei; Tan, Min; Tong, Li; Wang, Anna; Yin, Xianying; Guo, Jing; Martin, Robert C. C.; Bai, Ou; Li, Yan Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02589-7 PubMed DOI |
| 7. | Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis Author: Li, Yan; Yang, Wenjuan; Zheng, Yuanyuan; Dai, Weiqi; Ji, Jie; Wu, Liwei; Cheng, Ziqi; Zhang, Jie; Li, Jingjing; Xu, Xuanfu; Wu, Jianye; Yang, Mingwei; Feng, Jiao; Guo, Chuanyong Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02567-z PubMed DOI |
| 8. | Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression Author: Deng, Min; Zhang, Long; Zheng, Wenying; Chen, Jiale; Du, Nan; Li, Meiqi; Chen, Weiqing; Huang, Yonghong; Zeng, Ning; Song, Yuanbin; Chen, Yongming Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02586-w PubMed DOI |
| 9. | The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer Author: Xu, Youqin; Song, Mu; Hong, Ziyang; Chen, Wancheng; Zhang, Qianbing; Zhou, Jianlong; Yang, Chao; He, Zilong; Yu, Juanjuan; Peng, Xiaolin; Zhu, Qiuhong; Li, Shaotian; Ji, Kaiyuan; Liu, Minfeng; Zuo, Qiang Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02581-1 PubMed DOI |
| 10. | 被撤回的出版物: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer (Retracted article. See vol. 42, 2023) Author: Wu, Tangwei; Li, Xiaoyi; Yan, Ge; Tan, Zheqiong; Zhao, Dan; Liu, Shuiyi; Wang, Hui; Xiang, Yuan; Chen, Weiqun; Lu, Hongda; Liao, Xinghua; Li, Yong; Lu, Zhongxin Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02588-8 PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共5条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
